GlassScriptPhysician profile
Judith B Schartenberg
NPI 1164417192
$889.27
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $154 · 2021: $207 · 2022: $193.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $151.76 | 2020-2021 | |
| Alcon Vision LLC | $137.64 | 2019-2022 | |
| Shire North American Group INC | $128.90 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $71.07 | 2019-2020 | |
| Allergan, INC. | $60.99 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $56.47 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $53.94 | 2019-2021 | |
| Lombart Brothers, INC. | $30.65 | 2022 | |
| Bausch & Lomb Americas INC. | $23.60 | 2022 | |
| Rxsight INC | $20.53 | 2020 | |
| Oyster Point Pharma, INC. | $19.82 | 2022 | |
| Akorn Operating Company LLC | $18.53 | 2021 | |
| Akorn, INC. | $17.90 | 2019 | |
| Horizon Therapeutics Plc | $17.86 | 2022 | |
| Thea Pharma INC. | $17.82 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $17.26 | 2020 | |
| Abbvie INC. | $15.75 | 2022 | |
| Spark Therapeutics, INC. | $15.55 | 2021 | |
| Sun Pharmaceutical Industries INC. | $13.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Schartenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.